Gene · 2523
FUT1: fucosyltransferase 1 (H blood group)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FUT1: fucosyltransferase 1 (H blood group). Genes, record 2523. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2523
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P19526 | Galactoside alpha-(1,2)-fucosyltransferase 1 | 365 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents47
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46737 | P19526 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 655 | P19526 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4370 | P19526 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1621 | P19526 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1621 | P19526 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 655 | P19526 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4370 | P19526 | Espacenet |
| WO 2025093745 A1 | 2025-05-08 | 138 | P19526 | Espacenet |
| EP 4487869 A2 | 2025-01-08 | 193 | P19526 | Espacenet |
| KR 1020240027895 A | 2024-03-04 | 385 | P19526 | Espacenet |
1 to 10 of 47
See all 47 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants964
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FUT1 papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30DK078392 | Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease | 4 | 2025 |
| P50AA011999 | Southern California Research Center for ALPD and Cirrhosis | 4 | 2025 |
| R01HL095524 | Modulation of Lung Disease by Genetic/Epigenetic Profiling | 4 | 2025 |
| ZIAAG000965 | The Aging Genome Association Study "AGE-GAIN" | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 3 | 2025 |
| P30DK120515 | San Diego Digestive Diseases Research Center | 3 | 2025 |
| I01BX004594 | The role of pathobionts in alcoholic liver disease | 2 | 2025 |
1 to 10 of 964Source NIH's project files
See all 964 nih grantsPapers1,735
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hyperglycemia in Diabetes Drives Hepatic Fibrosis Through the Non-Enzymatic Function of HK2 and AGEs-mediated Matrix Stiffening. | Int J Biol Sci | 2026 | 42807844 | PubTator, text mining | PubMed |
| A novel FUT1 mutation c.268G>A (p.Gly90Ser) associated with the para-Bombay B blood phenotype. | Transfusion | 2026 | 42775622 | PubTator, text mining | PubMed |
| First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety. | Transfusion | 2026 | 42703786 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis and Molecular Modeling Identify ENO1 and Naftopidil as Candidates for Chronic Myelomonocytic Leukemia. | Curr Med Chem | 2026 | 42670058 | PubTator, text mining | PubMed |
| Boosting HSC functions: l-carnitine takes center stage. | Blood | 2026 | 42560722 | PubTator, text mining | PubMed |
| Cross-Correction in HSC Gene Therapy for Metachromatic Leukodystrophy. | N Engl J Med | 2026 | 42526029 | PubTator, text mining | PubMed |
| Integration of single-cell sequencing and transcriptomic analysis to identify novel diagnostic biomarkers for pre-eclampsia. | BMC Pregnancy Childbirth | 2026 | 42477616 | PubTator, text mining | PubMed |
| ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development. | Cancer Res | 2026 | 42466903 | PubTator, text mining | PubMed |
| Microtubule-Targeting Drugs Induce Mesenchymal-Epithelial Transition in Hepatic Stellate Cells. | Liver Int | 2026 | 42402720 | PubTator, text mining | PubMed |
| Identification and protein modelling analysis of a homozygous FUT1*01W.09 variant in a Thai patient with the para-Bombay phenotype. | Transfus Med | 2026 | 42392576 | PubTator, text mining | PubMed |
1 to 10 of 1,735
See all 1,735 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2523
GET https://conductscience.org/api/genes/v1/2523/patents?page=2